Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Hay, Kevin A.
Turtle, Cameron J.
Funding for this research was provided by:
University of British Columbia Clinical Investigator Program
unspecified valid from 2017-01-21